What is ENT & Allergy?
ENT & Allergy of Delaware stands as a premier provider of comprehensive medical services, specializing in ear, nose, and throat care, audiology, asthma, allergy, and immunology. By integrating board-certified specialists with advanced surgical and diagnostic capabilities, the practice delivers high-quality, patient-centered care across Wilmington, Middletown, and Newark. The organization distinguishes itself through a focus on effective healthcare cost management and the delivery of sophisticated treatment options for patients of all ages, solidifying its reputation as a cornerstone of regional specialty medicine.
How much funding has ENT & Allergy raised?
ENT & Allergy has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in ENT & Allergy
PPP
Public-Private Partnership
What's next for ENT & Allergy?
Looking ahead, the infusion of capital will likely catalyze the expansion of ENT & Allergy's service delivery models and technological capabilities. As the organization navigates this major enterprise-level funding phase, the focus will shift toward optimizing patient outcomes through enhanced diagnostic tools and potentially increasing its physical presence in key Delaware corridors. By leveraging this financial backing, the practice is poised to strengthen its competitive advantage in the specialty care sector, ensuring that its clinical operations remain at the forefront of medical innovation and operational efficiency.
See full ENT & Allergy company page
